Drug Trafficking: Director of the White House Office of National Drug Control Policy Releases the Administration’s National Drug Control Policy

Presidential Proclamation: President Trump Proclaims February 2019 as American Heart Month


Monday, January 28

Medicare: Senate Finance Committee Chairman Chuck Grassley Presses HHS and CMS for Explanation of Potential Increasing Costs to Medicare Laboratory Services

Price Increases: Committee on Oversight and Reform Hold first Hearing Examining Rising Drug Prices

Tuesday, January 29

Community Health Centers: Ranking Member Patty Murray (D-WA) Speech on Long-Term Funding for Critical Primary Care Programs

  • Senate Health Committee Chairman Lamar Alexander (R-TN) Addresses Congress’s Need to Act Soon

Drug Pricing: Senate Finance Committee Chairman Chuck Grassley’s Statement at Hearing on Drug Pricing

Pre-Existing Conditions: Ways and Means Committee Chairman Richard Neal’s Statement from Hearing on Protecting Americans with Pre-Existing Conditions

Wednesday, January 30

Veteran’s Community Care: Chairman of the Senate Committee on Veterans’ Affairs Johnny Isakson (R-GA) and Ranking Member of the House Committee on Veterans’ Affairs Dr. Phil Roe (R-TN) Issue Joint Statement on Proposed Eligibility Criteria for Veterans’ Community Care

Insulin Prices: Energy and Commerce Leaders Send Letter to Pharmaceutical Companies Requesting Information on Skyrocketing Insulin Prices

Health Subcommittee: Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) and Health Subcommittee Chairwoman Anna Eshoo (D-CA) Announce Hearing that Will Discuss the Impacts of Texas v. United States

Thursday, January 31

Geriatricians: Senator Susan Collins (R-ME) and Senator Bob Casey (D-PA) Introduce Geriatrics Workforce Improvement Act

Medicare: Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) and Ways & Means Committee Chairman Richard Neal (D-MA) Release Joint Statement on Trump Administration’s Rebate Proposal

Friday, February 1

National Drug Control Strategy: Chairman of the Committee on Oversight and Reform Elijah E. Cummings Announces Director of the Office of National Drug Control Policy Will Testify at Hearing


Monday, January 28

FDA: Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health on Record Year for Device Innovation

NIH: Study Reveals Biomarkers Could Help Identify Those at Risk of Severe PTSD

  • NIH-funded Clinical Trial Finds evidence Linking Brain and Vascular Health

Tuesday, January 29

CDC: CDC Submits Information Collection Request to Obtain Comments From the Public and Affected Agencies

Wednesday, January 30

CMS: CMS Proposes Medicare Advantage and Part D Payment and Policy Updates to Maximize Competition and Coverage

FDA: FDA Commissioner Scott Gottlieb, M.D. Statement on Agency’s Efforts to Enhance the Utility of Orange Book to Foster Drug Competition

  • FDA Commissioner Scott Gottlieb, M.D. Statement on Improving Patient Access to Medicines

NIH: Scientists Develop Tool to Measure Success of HIV Cure Strategies

NIH: New Study Identifies Risk Factors for Neuropsychiatric Conditions After Concussion

Thursday, January 31

CMS: CMS Announces Opportunity for Public Comment on CMS’ Intention to Collect Information from the Public

HHS: New Proposed Rule Adopts Modification to the Requirements for the Use of the Telecommunication Standard Implementation Guide

Friday, February 1

FDA: FDA Announces the Availability of Draft Guidance for ANDA Submissions

  • FDA Announces Availability of Final guidance for Immunogenicity Testing of Therapeutic Protein ProdGcts
  • FDA Announces Availability of Final Guidance of Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices


Meeting: National Heart, Lung, and Blood Advisory Council
February 5, 2019 8:30 AM – 12:00 PM
National Institutes of Health, Porter Neuroscience Research Center, Building 35A Convent Drive, Bethesda, MD 20892

Meeting: Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group; Surgery, Anesthesiology and Trauma Study Section
February 6-7, 2019 8:00 AM – 6:00 PM
Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814

Meeting: Integrative, Functional and Cognitive Neuroscience Integrated Review Group
February 7-8, 2019 8:00 AM – 6:00 PM
Renaissance Harborplace Hotel, 202 East Pratt Street, Baltimore, MD 21202

Meeting: National Institute of Mental Health Special Emphasis Panel; Treatment Development—Psychosocial Interventions
February 7, 2019 9:00 AM – 4:30 PM
National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting)

Meeting: National Advisory Council for Complementary and Integrative Health
February 8, 2019 8:30 AM – 9:45 AM
National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892

Meeting: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel
February 8, 2019 12:00 PM – 5:00 PM
Baltimore Marriott Waterfront, 700 Aliceanna Street, Baltimore, MD 21202

Meeting: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Brain Review Meeting
February 10-11, 2019 1:00 PM – 6:00 PM
Kimpton Hotel Monaco, 700 F. Street NW, Washington, DC 20004

Meeting: Digestive, Kidney and Urological Systems Integrated Review Group; Pathobiology of Kidney Disease Study Section
February 12-13, 2019 8:00 AM – 6:00 PM
Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814

Meeting: Community Preventive Services Task Forces (CPSTF)
February 13, 2019 8:30 AM – 6:00 PM & February 14, 2019 8:30 AM – 1:00 PM
CDC Edward R. Roybal Campus, Centers for Disease Control and Prevention Headquarters (Building 19), 1600 Clifton Road NE, Atlanta, GA 30329

Meeting: National Heart, Lung, and Blood Institute Special Emphasis Panel
February 15, 2019 8:00 AM – 4:00 PM
Sheraton Baltimore Washington Airport Hotel, 1100 Old Elkridge Landing Road, Linthicum Heights, MD 21090

National Institute of Neurological Disorders and Stroke
Meeting: National Advisory Neurological Disorders and Stroke Council.
February 14th – 15th 12:30 PM – 6:00 PM
Porter Neuroscience Research Center, Building 35A, Convent Drive, Bethesda, MD 20892

Meeting: Brain Disorders and Clinical Neuroscience Integrated Review Group; Acute Neural Injury and Epilepsy Study Section
February 21-22, 2019 8:00 AM – 5:00 PM
The Dupont Hotel, 1500 New Hampshire Avenue NW, Washington, DC 20036

Meeting: Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Treatment (CSAT) National Advisory Council (NAC) Meeting
February 27, 2019 9:00 AM – 5:00 PM
5600 Fishers Lane, Room 5N54, Rockville, MD

Meeting: Advisory Committee on Immunization Practices (ACIP)
February 27, 2019 8:00 AM – 5:30 PM & February 28, 2019 8:30 AM – 3:30 PM
CDC, 1600 Clifton Road, NE, Tom Harkin Global Communications Center, Building 19, Kent `Oz’ Nelson Auditorium, Atlanta, GA

Meeting: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel and Occupational Safety and Health Education and Research Centers (ERC)
February 12-13, 2019 8:30 AM – 5:00 PM
Hilton Alexandria Old Town, 1767 King Street, Alexandria, Virginia 22314

Meeting: Neurological Devices Panel of the Medical Devices Advisory Committee
March 21,2019 8 AM – 5 PM
Hilton Washington, DC North/Gaithersburg, Salons A, B, C and D, 620 Perry Pkwy., Gaithersburg, MD 20877.


Leave a Reply